Dr. Christopher Mulder, DO

NPI: 1356577951
Total Payments
$4,603
2024 Payments
$1,672
Companies
26
Transactions
261
Medicare Patients
1,686
Medicare Billing
$259,725

Payment Breakdown by Category

Food & Beverage$4,570 (99.3%)
Education$33.30 (0.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,570 259 99.3%
Education $33.30 2 0.7%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $940.63 63 $0 (2024)
Janssen Biotech, Inc. $687.20 37 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $455.77 26 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $443.20 29 $0 (2024)
Regeneron Healthcare Solutions, Inc. $386.96 19 $0 (2024)
Celgene Corporation $261.16 20 $0 (2024)
Lilly USA, LLC $186.77 7 $0 (2024)
Phathom Pharmaceuticals, Inc. $172.54 4 $0 (2024)
Amgen Inc. $135.16 7 $0 (2023)
IRONWOOD PHARMACEUTICALS, INC $129.45 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,672 85 Janssen Biotech, Inc. ($309.67)
2023 $1,536 92 ABBVIE INC. ($444.85)
2022 $1,086 68 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($272.62)
2021 $309.76 16 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($93.45)

All Payment Transactions

261 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
12/18/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $32.41 General
Category: Immunology
12/18/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $14.24 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
12/11/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $21.64 General
Category: IMMUNOLOGY
12/05/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $100.85 General
Category: Immunology
12/04/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $13.10 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/03/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $15.39 General
Category: INTERNAL MEDICINE
12/02/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $10.34 General
Category: IMMUNOLOGY
11/27/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $17.13 General
Category: IMMUNOLOGY
11/25/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.10 General
Category: Immunology
11/20/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.17 General
Category: Gastroenterology
11/20/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $18.95 General
Category: GI
11/18/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $15.86 General
Category: IMMUNOLOGY
11/18/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $6.16 General
Category: INTERNAL MEDICINE
11/15/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $11.46 General
Category: IMMUNOLOGY
11/12/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $16.66 General
Category: GASTROENTEROLOGY
11/11/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $3.30 General
Category: IMMUNOLOGY
11/01/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $20.22 General
Category: INTERNAL MEDICINE
10/30/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $21.64 General
Category: INTERNAL MEDICINE
10/18/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $19.22 General
Category: Immunology
10/15/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $2.21 General
Category: INFLAMMATION AND IMMUNOLOGY
10/14/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $15.11 General
Category: INTERNAL MEDICINE
10/14/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $13.14 General
Category: IMMUNOLOGY
10/14/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $5.43 General
Category: INFLAMMATION AND IMMUNOLOGY
10/09/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.90 General
Category: Neuroscience
10/03/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.79 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 469 495 $228,782 $43,554
2022 13 439 4,896 $385,107 $121,527
2021 15 567 1,415 $381,986 $79,577
2020 9 211 217 $102,767 $15,067
Total Patients
1,686
Total Services
7,023
Medicare Billing
$259,725
Procedure Codes
51

All Medicare Procedures & Services

51 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 80 84 $75,600 $15,596 20.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 83 85 $46,750 $6,349 13.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 53 54 $39,420 $5,538 14.0%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 17 17 $11,900 $2,756 23.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 29 37 $5,069 $2,333 46.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 26 26 $5,200 $2,057 39.6%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 12 12 $8,400 $2,006 23.9%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 14 15 $4,950 $1,411 28.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 15 15 $3,900 $1,366 35.0%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 11 11 $7,700 $1,313 17.0%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 11 11 $6,270 $1,223 19.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 13 15 $2,055 $829.86 40.4%
43450 Dilation of esophagus Facility 2023 14 14 $2,856 $406.00 14.2%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Facility 2023 91 99 $8,712 $371.75 4.3%
J3380 Injection, vedolizumab, 1 mg Office 2022 11 3,600 $100,800 $61,327 60.8%
J1745 Injection, infliximab, excludes biosimilar, 10 mg Office 2022 14 860 $94,600 $24,636 26.0%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 75 76 $67,320 $14,059 20.9%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 89 91 $48,730 $6,402 13.1%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 39 41 $29,080 $3,831 13.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 38 42 $5,754 $2,645 46.0%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2022 18 19 $6,270 $1,822 29.1%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 14 14 $9,610 $1,773 18.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 22 22 $4,400 $1,747 39.7%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 16 24 $3,288 $1,277 38.8%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2022 11 11 $5,570 $1,107 19.9%

About Dr. Christopher Mulder, DO

Dr. Christopher Mulder, DO is a Internal Medicine healthcare provider based in Clive, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1356577951.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Mulder, DO has received a total of $4,603 in payments from pharmaceutical and medical device companies, with $1,672 received in 2024. These payments were reported across 261 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,570).

As a Medicare-enrolled provider, Mulder has provided services to 1,686 Medicare beneficiaries, totaling 7,023 services with total Medicare billing of $259,725. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Gastroenterology, Gastroenterology
  • Location Clive, IA
  • Active Since 06/09/2009
  • Last Updated 11/03/2020
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1356577951

Products in Payments

  • SKYRIZI (Biological) $396.36
  • STELARA (Biological) $339.37
  • RINVOQ (Biological) $314.73
  • DUPIXENT (Biological) $304.96
  • ENTYVIO (Biological) $293.23
  • ZEPOSIA (Drug) $291.54
  • XIFAXAN (Drug) $250.14
  • TRULANCE (Drug) $193.06
  • REMICADE (Biological) $186.87
  • VOQUEZNA (Drug) $172.54
  • TREMFYA (Drug) $160.96
  • OMVOH (Drug) $154.88
  • Linzess (Drug) $129.45
  • IBSRELA (Drug) $121.24
  • GATTEX (Drug) $105.29
  • DIFICID (Drug) $88.95
  • XELJANZ (Drug) $85.05
  • HUMIRA (Biological) $81.60
  • VIBERZI (Drug) $75.55
  • AMJEVITA (Biological) $68.53

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Clive